| Product Name | MF | CAS | Details |
|---|
| H-KTGGPIYKR-OH | Details |
| 1-Bromo-4-(1-propen-2-yl)benzene | C9H9Br | 6888-79-5 | Details |
| Echinacea purpurea extract - 4% Echinacea polyphenols | C22H18O11 | 90028-20-9 | Details |
| 2-((4-chlorophenyl)sulfonyl)-3-(2-(3-chloro-5-(trifluoromethyl)(2-pyridyl)oxy)-3-methoxyphenyl)prop-2-enenitrile | C22H13Cl2F3N2O4S | 1025615-35-3 | Details |
| 4-Hydroxyquinoline-2-carboxylic acid hydrate | C10H7NO3.H2O | 345909-35-5 | Details |
| 3-Bromobiphenyl | C12H9Br | 2113-57-7 | Details |
| 2-Naphthyl-alpha-L-fucopyranoside | C16H18O5 | 63503-05-9 | Details |
| 6-(Morpholine-4-carbonyl)cyclohex-3-ene-1-carboxylic acid | C12H17NO4 | 478040-26-5 | Details |
| N,2-Dimethyl-3-(methylamino)propanamide | C6H14N2O | 137937-95-2 | Details |
| rac-trans paroxol | C13H18FNO | 109887-53-8 | Details |
| 4-(1,3-Thiazol-2-yl)butan-2-one | C7H9NOS | 933740-86-4 | Details |
| (E)-4-Alloxycarboxyl tamoxifen | C30H33NO4 | 1287191-58-5 | Details |
| Phosphorylcholine chloride | C5H15ClNO4P | 107-73-3 | Details |
| PPP1R13B Blocking Peptide | Details |
| 1-(2-Aminoethoxy)-4-(propan-2-yl)benzene hydrochloride | C11H18ClNO | 1158196-11-2 | Details |
| Methyl 2-[4-(3-hydroxypropyl)-1H-1,2,3-triazol-1-yl]acetate | C8H13N3O3 | 1564569-53-4 | Details |
| 1-Chloro-3-methoxy-3-methylbutan-2-one | C6H11ClO2 | 57539-98-7 | Details |
| 4-Methoxystyrene | C9H10O | 637-69-4 | Details |
| 3,4-dibromo-6-(trifluoromethyl)pyridazine | C5HBr2F3N2 | 1073525-71-9 | Details |
| Methyl 2-O-(a-D-mannopyranosyl)-a-D-mannopyranoside | C13H24O11 | 59571-75-4 | Details |
| 8-Bromoquinoxaline-6-carbonitrile | C9H4BrN3 | 1378254-84-2 | Details |
| Methyl 4-({[1-(ethanesulfonyl)piperidin-4-yl]carbamoyl}amino)benzoate | C16H23N3O5S | 1240529-44-5 | Details |
| phenyl(4-(4-phenylphenyl)(2,5-thiazolyl))amine, hydrobromide | C21H17BrN2S | 42056-68-8 | Details |
| 5-Deoxy-D-arabinose | C5H10O4 | 67968-47-2 | Details |
| anti-Human Calprotectin Antibody Monoclonal | Details |
| Methyl 4-(4-oxopiperidin-1-yl)butanoate | C10H17NO3 | 1096321-89-9 | Details |
| 3-(4-Methylpyrrolidin-2-yl)pyridine | C10H14N2 | 603090-13-7 | Details |
| 6-Methyl-N-[(E)-1-pyridin-2-ylethylideneamino]-4a,5-dihydro-2H-[1,2,4]triazino[5,6-b]indol-3-amine | C17H17N7 | 1622945-04-3 | Details |
| 1-[(3-Fluorophenyl)methyl]piperidin-4-one | C12H14FNO | 155868-53-4 | Details |
| CD153 antibody (PE) | Details |
| (Z)-9-Hexadecenal | C16H30O | 56219-04-6 | Details |
| GSTM5 antibody | Details |
| 3-(Propan-2-yl)-2-azaspiro[3.4]oct-6-en-1-one | C10H15NO | 1909325-92-3 | Details |
| FLJ13798 antibody | Details |
| FBXL7 antibody | Details |
| 2-[1-(Methanesulfonylmethyl)cyclopropyl]ethan-1-amine hydrochloride | C7H16ClNO2S | 1955531-16-4 | Details |
| Methyl 2-(4-bromo-6-methylpyridin-2-yl)acetate | C9H10BrNO2 | 1805567-32-1 | Details |
| 2-Methyl-4-cyclopropylphenylboronic acid pinacol ester | C16H23BO2 | 2223040-90-0 | Details |
| 7',8'-Dihydro-5'H-spiro[1,3-dioxolane-2,6'-quinazoline]-2'-amine | C10H13N3O2 | 115689-67-3 | Details |
| H-VMPPRTLLL-OH | Details |
| 1-Chloro-4,5-difluoro-2-iodobenzene | C6H2ClF2I | 1261629-20-2 | Details |
| 5-Bromo-2-chloroquinoxaline | C8H4BrClN2 | 1379359-02-0 | Details |
| H-EYFYTSGK-OH | Details |
| 2-Hydroxy-5-nitropyridine | C5H4N2O3 | 5418-51-9 | Details |
| PKC gamma antibody | Details |
| 2-Naphthalenyl hydrazine hydrochloride | C10H11ClN2 | 2243-58-5 | Details |
| 4-Vinylpyridine, stabilized with 100ppm Hydroquinone | C7H7N | 100-43-6 | Details |
| Methyl 3-(chlorosulfonyl)-4-methoxybenzoate | C9H9ClO5S | 192323-12-9 | Details |
| VEGFD antibody | Details |
| [3-(3,3,3-Trifluoropropoxy)pyridin-4-yl]methanamine | C9H11F3N2O | 1551394-28-5 | Details |
| 3-(3-Methyl-2,5-dioxopyrrolidin-1-yl)benzoic acid | C12H11NO4 | 832739-55-6 | Details |
| (4R,6R)-4-Hydroxy-2,8,14-triazatricyclo[8.4.0.0,2,6]tetradeca-1(14),10,12-trien-7-one | C11H13N3O2 | 2059913-86-7 | Details |
| N-(aza(3-oxocyclohexylidene)methyl)-2-((4-methylphenyl)sulfonyl)ethanamide | C15H18N2O4S | 1025667-34-8 | Details |
| Ethyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate | C7H9BrN2O2 | 1639289-05-6 | Details |
| OTUD6B antibody | Details |
| 5-Ethyl-3-methylpyrrolidin-2-one | C7H13NO | 1215126-78-5 | Details |
| 4-(4-Bromophenyl)morpholine | C10H12BrNO | 30483-75-1 | Details |
| Indium - 99.999% trace metals basis - particle size 1 - 6 mm | In | 7440-74-6 | Details |
| 3-(3-Aminophenyl)-5-ethylimidazolidine-2,4-dione hydrochloride | C11H14ClN3O2 | 1803562-16-4 | Details |
| 5-Methyl-1-(2-{5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepin-3-yl}propyl)-1H-pyrazol-3-amine | C14H22N6 | 1174880-95-5 | Details |
| 5-Methyl-2,3-dihydro-1H-inden-4-ol | C10H12O | 20294-31-9 | Details |
| 2-{[4-Ethyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(4-ethylphenyl)acetamide | C19H21N5OS | 525582-84-7 | Details |
| 4-Chloro-2-(2-phenoxyacetamido)benzoic acid | C15H12ClNO4 | 69764-05-2 | Details |
| SLC7A2 Blocking Peptide | Details |
| OSTLP2 antibody | Details |
| 6-Ethoxy-N-(piperidin-4-yl)pyrimidin-4-amine | C11H18N4O | 1354088-12-2 | Details |
| rac-(1R,2S)-2-Aminocycloheptane-1-carboxylic acid hydrochloride | C8H16ClNO2 | 1033756-97-6 | Details |
| 6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-amine | C10H8N4S | 10136-64-8 | Details |
| (1S,2S)-2-(Methoxymethyl)cyclopropane-1-carboxylic acid | C6H10O3 | 2377005-25-7 | Details |
| 3-[(Cyclopropylmethyl)sulfamoyl]benzoic acid | C11H13NO4S | 954579-38-5 | Details |
| 2-[2-(Aminomethyl)piperidin-1-yl]ethan-1-ol | C8H18N2O | 1306571-74-3 | Details |
| 4-Bromo-1',5'-dimethyl-1H,1'H-3,4'-bipyrazole | C8H9BrN4 | 1006334-21-9 | Details |
| Bz-Gly-D-Lys-OH | C15H21N3O4 | 108392-04-7 | Details |
| rac-tert-Butyl N-[(1R,2R)-2-hydroxycycloheptyl]carbamate | C12H23NO3 | 2219370-84-8 | Details |
| 4-Hydroxy-3-nitrophenylethylamine nitrate | C8H11N3O6 | 63195-79-9 | Details |
| 3-Methoxy-4-[(phenylsulfanyl)methyl]benzaldehyde | C15H14O2S | 438532-51-5 | Details |
| 2,2-Difluoro-2-(3-methyl-1H-1,2,4-triazol-5-yl)ethan-1-amine | C5H8F2N4 | 1803608-53-8 | Details |
| 2-{[2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid, trifluoroacetic acid | 2377032-39-6 | Details |
| H-FITC-FLPLLILGSLLMTPPVIQAIHDAQR-NH2 | Details |
| Biotin-Obestatin (rat) | Details |
| alpha Tubulin 3C antibody | Details |
| Triclabendazole antibody | Details |
| Methyl 3,4-isopropylidene-b-L-arabinopyranoside | C9H16O5 | 6960-39-0 | Details |
| (5S)-2,3,4,5-Tetrahydro-1-benzothiepin-5-ol | C10H12OS | 1394680-91-1 | Details |
| 1-(4-Chloro-3-fluorophenyl)-2-(propan-2-yloxy)ethan-1-ol | C11H14ClFO2 | 1461709-04-5 | Details |
| N-(2-Amino-ethyl)-2-(benzyl-phenyl-amino)-acetamide | C17H21N3O | 26953-37-7 | Details |
| 1,1,1-Trifluoro-3-methylpentan-2-amine hydrochloride | C6H13ClF3N | 1787896-72-3 | Details |
| 5-(Trifluoromethyl)-1H-pyrrole-3-sulfonyl chloride | C5H3ClF3NO2S | 1803571-48-3 | Details |
| 2,4,6-Trimethylbenzene-1-carbothioamide | C10H13NS | 57182-71-5 | Details |
| CCDC144B antibody | Details |
| 1-Bromo-3-[(methylsulfanyl)methyl]benzene | C8H9BrS | 76354-12-6 | Details |
| Dutasteride EP impurity D | C27H28F6N2O2 | 2989829-97-0 | Details |
| H-DIYSTDYYR-OH | Details |
| Spiro[4.5]decan-2-amine hydrochloride | C10H20ClN | 2126-95-6 | Details |
| 6-Azaspiro[4.5]decane-8-carboxylic acid hydrochloride | 2377033-88-8 | Details |
| Z-Gly-Pro-OSu | C19H21N3O7 | 38417-02-6 | Details |
| Ac-CCLLMPPPPPLFPPPFF-NH2 | Details |
| SIVmac239 - 23 | C76H125N23O26 | Details |
| 1-(1-Methyl-1H-1,2,3,4-tetrazol-5-yl)ethan-1-amine hydrochloride | C4H10ClN5 | 2138537-66-1 | Details |
| 2-Chloro-N-[2-(thiophen-3-yl)ethyl]acetamide | C8H10ClNOS | 135709-70-5 | Details |
| Product Total： Product Page： | ||||
| 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 | ||||